AQR Apex UCITS Fund IAE1 EUR Acc

Register to Unlock Ratings
Performance History31/05/2024
Growth of 1,000 (GBP) Advanced Graph
AQR Apex UCITS Fund IAE1 EUR Acc
Fund-----
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
25/06/2024
 EUR 100.60
Day Change -0.17%
Morningstar Category™ Multistrategy USD
ISIN LU2793905717
Fund Size (Mil)
25/06/2024
 USD 487.88
Share Class Size (Mil)
25/06/2024
 EUR 5.64
Max Initial Charge -
Ongoing Charge
13/05/2024
  1.80%
Investment Objective: AQR Apex UCITS Fund IAE1 EUR Acc
The investment objective of the Fund is to seek total returns commensurate with its long-term risk target. The Fund will allocate its assets to three investment sub-strategies, each sub-strategy having a distinguishable set of investment objectives and the Market Neutral Security Selection Strategy. There can be no assurance that the Fund will achieve its investment objective.
Returns
Trailing Returns (GBP)25/06/2024
YTD-
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield -
Management
Manager Name
Start Date
Yao Ooi
01/02/2017
Andrea Frazzini
01/02/2017
Click here to see others
Inception Date
25/04/2024
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Not BenchmarkedMorningstar US Con Tgt Alloc NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthNot Specific
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AQR Apex UCITS Fund IAE1 EUR Acc-
Morningstar Style Box®
Equity Style
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Fixed Income
Effective Maturity-
Effective Duration-
Top 5 Regions%
No Data Available
Top 5 Sectors%
No Data Available
Top 5 HoldingsSector%
No Data Available
AQR Apex UCITS Fund IAE1 EUR Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures